Charta Health Pitch Deck: Slide-by-Slide Breakdown

The Lean Approach to Healthcare Fintech

Charta Health’s pitch deck is a masterclass in brevity. In just 12 slides, the company secured $8.1M in seed funding from some of the most prestigious names in venture capital. The deck doesn't rely on complex diagrams or futuristic visions; instead, it focuses on a massive, expensive inefficiency in the US healthcare system and offers a direct, AI-powered solution to fix it. By framing their product as a 'pure upside' tool, Charta removes the friction typically associated with healthcare enterprise sales.

Slide 1: Title Slide

The deck opens with a clean, professional title slide featuring the company logo and the tagline: "Intelligent Revenue Capture with AI Chart Review." The imagery is a soft-focus lifestyle shot of a healthcare professional, signaling a focus on the human element of the industry despite the technical nature of the product. The branding is minimalist, using a muted green palette that suggests stability and growth.

Slide 2: The Problem

Slide 2 identifies a staggering inefficiency. It states that "100% of US healthcare providers review medical charts for revenue and clinical opportunities," a process that costs "at least $85 billion every year." The 'hook' is the final line: "Yet, less than 2% of charts are actually reviewed." This creates an immediate gap between what providers want to do (review all charts) and what they can afford to do, setting the stage for an automated solution.

Slide 3: The Opportunity

This slide digs into the 'why' behind the problem. It lists two primary barriers: cost and time. According to Slide 3, a single chart review can cost as much as "$275 to review, with an average cost of $80." Furthermore, the process takes "30-60 minutes to complete," which is incompatible with the 24-hour window required for claim submissions. This slide effectively argues that the current manual process is fundamentally unscalable.

Slide 4: The Solution

The solution is presented in a single, bold sentence: "Charta leverages LLMs to perform a fully autonomous pre-bill review of every chart for revenue and clinical opportunities." By specifying 'pre-bill,' Charta positions itself at the most critical point in the revenue cycle—before the money is lost or the claim is denied. The mention of LLMs (Large Language Models) anchors the company in the current AI wave without over-explaining the tech.

Slide 5: Product Demo

Slide 5 is a placeholder for a product demo, showing a laptop mockup with a dense, data-rich interface. The UI appears to show a 'Review Audit' screen with color-coded alerts (red and green) and a detailed 'Note' section. This suggests a high level of transparency, allowing human users to see exactly why the AI flagged a specific chart or code.

Slide 6: Why Charta?

This is the 'Value Proposition' slide, and it is the strongest in the deck. It breaks down the benefits into three categories:

Revenue Discovery: Increase revenue up to 15.2% , with an average increase of 11% . · Denial Prevention: Identify and prevent over 70% of denials before they happen. · Audit & Compliance: Achieve 100% pre-bill audit coverage at less than 1% of the cost.

These are hard, quantifiable numbers that appeal directly to the CFO of a healthcare system.

Slide 7: Insights and Sales Momentum

Slide 7 addresses the 'Go-To-Market' strategy by highlighting their early success. The headline claims a "100% close rate from proof-of-concept to signed contract." They attribute this to a 'white-glove' design that delivers a POC within days and a positioning strategy as a "pure upside, ROI-guaranteed solution." This slide is designed to de-risk the investment by showing that the market is already biting.

Slide 8: Case Studies

To back up the claims on Slide 6, Slide 8 provides three specific case studies:

A national telehealth provider saw a 12.6% increase in primary care revenue. · A leading national provider with 100+ facilities captured $1.1M in annual revenue . · A remote patient monitoring provider achieved 100% audit coverage at less than 1% cost.

The use of 'National' and 'Leading' as descriptors for these clients suggests that Charta is already playing at the enterprise level.

Slide 9: Leadership Team

The team slide is a heavy hitter. Justin Liu (CEO) and Scott Morris (CTO) both come from Rockset , a data infrastructure company acquired by OpenAI . Liu also has a background at Google, and Morris was a founding engineer at Rockset. They are joined by Dr. Caesar Djavaherian (CMO) , co-founder of Carbon Health , and Tam Pham (VP Healthcare Solutions) , who has three decades of experience at major health plans like SCAN Health Plan and Agilon Health . This mix of high-end AI engineering and deep clinical/insurance expertise is likely what secured the $8.1M round.

Slide 10-12: Closing and Legal

Slide 10 is a simple 'Questions?' slide, Slide 11 is a standard legal disclaimer, and Slide 12 is a promotional slide for the deck source. Notably, there is no 'Ask' slide. In high-demand seed rounds, founders often omit the specific dollar amount and terms from the deck to maintain flexibility in negotiations or because the round is already oversubscribed by the time the deck is widely circulated.

What Makes This Deck Work

The Charta Health deck works because it treats AI as a utility, not a miracle. Instead of promising to 'revolutionize healthcare,' it promises to find the 11% of revenue that providers are already entitled to but are too busy to claim. The focus on 'pre-bill' review is a genius tactical choice; it turns the product into a profit center rather than a cost center. Furthermore, the team slide perfectly balances technical 'builders' (the Rockset/OpenAI connection) with industry 'insiders' (the Carbon Health/Agilon connection), which is the exact profile investors look for in the 'AI for X' category.

What Is Missing

For a seed deck, there are several standard omissions that might have been intentional: 1. TAM/SAM/SOM: There is no slide showing the total addressable market. While the $85B problem is mentioned on Slide 2, a traditional market sizing slide is absent. 2. Competition: The deck does not mention competitors like Fathom or other AI medical coding startups. This suggests the founders believe their 'pre-bill audit' niche is distinct enough to stand alone. 3. The Ask: As mentioned, the lack of an 'Ask' slide is common in rounds led by top-tier firms like Bain Capital Ventures, where the deal terms are often settled before the final deck is polished. 4. Unit Economics: There is no mention of CAC (Customer Acquisition Cost) or LTV (Lifetime Value), though this is expected at the Seed stage where the focus is on early traction and POC-to-contract conversion rates.

Founder's Playbook: What to Copy

1. The 'Pure Upside' Frame: If your product saves money or finds lost revenue, lead with that. Slide 7’s mention of 'ROI-guaranteed' is a powerful way to shorten sales cycles. 2. Pedigree Alignment: If your team has a 'win' (like the Rockset acquisition by OpenAI), put it front and center. It validates that the team can build at scale. 3. Quantified Case Studies: Don't just say you helped a client; say you increased their revenue by 12.6% or saved them $1.1M. Specificity creates credibility. 4. Focus on Friction: Slide 7 explicitly mentions that they don't require 'adoption of new workflows.' In healthcare, where change management is the biggest hurdle, this is a massive selling point. Founders should always highlight how their product fits into existing systems rather than disrupting them.